Lixiana OD tablets 30mg, manufactured by Daiichi Sankyo, contain edoxaban tosilate hydrate, an oral anticoagulant that inhibits activated blood coagulation factor X. It is used to prevent venous thromboembolism following orthopedic surgery and to prevent ischemic stroke in patients with non-valvular atrial fibrillation. The YJ code is 3339002F5025, and the standard is 30mg 1 tablet.
Lixiana OD tablets 30mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →